Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We describe a method to measure the velocity of phagosomes moving towards the cell center in living cells infected with or without the human immunodeficiency virus (HIV) type 1, using spinning disk confocal fluorescence microscopy to identify fluorescent infected cells and bright field microscopy to detect phagosomes.

Abstract

Macrophages are phagocytic cells that play a major role at the crossroads between innate and specific immunity. They can be infected by the human immunodeficiency virus (HIV)-1 and because of their resistance to its cytopathic effects they can be considered to be persistent viral reservoirs. In addition, HIV-infected macrophages exhibit defective functions that contribute to the development of opportunistic diseases.

The exact mechanism by which HIV-1 impairs the phagocytic response of macrophages was unknown. We had previously shown that the uptake of various particulate material by macrophages was inhibited when they were infected with HIV-1. This inhibition was only partial and phagosomes did form within HIV-infected macrophages. Therefore, we focused on analyzing the fate of these phagosomes. Phagosome maturation is accompanied by migration of these compartments towards the cell center, where they fuse with lysosomes, generating phagolysosomes, responsible for degradation of the ingested material. We used IgG-opsonized Sheep Red Blood Cells as a target for phagocytosis. To measure the speed of centripetal movement of phagosomes in individual HIV-infected macrophages, we used a combination of bright field and fluorescence confocal microscopy. We established a method to calculate the distance of phagosomes towards the nucleus, and then to calculate the velocity of the phagosomes. HIV-infected cells were identified thanks to a GFP-expressing virus, but the method is applicable to non-infected cells or any type of infection or treatment.

Introduction

Macrophages play a major role in the innate immune system and in homeostasis. They are professional phagocytes that internalize and eliminate pathogens and debris by a process called phagocytosis 1,2. The phagosome, the closed compartment that forms after the engulfment of particulate material, undergoes a series of fusion and fission events with endocytic compartments, leading to a degradative compartment called the phagolysosome. This compartment has an acidic pH, due to the acquisition of proton-pumping v-ATPases, contains hydrolytic enzymes and is enriched in lysosomal-associated membrane proteins (LAMPs). The maturation of phagosomes is accompanied by their migration on microtubules 3,4 towards the cell center to reach a perinuclear location where lysosomes are accumulated.

Many pathogens have been reported to hijack phagosome maturation, including bacteria with intracellular lifestyles that modify the vacuolar environment where they reside 5. The Human Immunodeficiency Virus (HIV)-1 targets macrophages in addition to T cells. As macrophages are resistant to the cytopathic effects of the virus, unlike T cells, they can be considered as a reservoir for the virus. In addition, macrophages infected with HIV-1 show defective phagocytic functions and contribute to the emergence of opportunistic diseases. In particular, severe invasive non-typhoidal Salmonella disease caused by Salmonella Typhimurium ST313 has been prevalent for the last three decades in sub-Saharan African children or adults infected with HIV 6. It has been estimated that the risk of developing tuberculosis is more than 20 times greater in people living with HIV than among those without HIV infection.

For all these reasons, it is important to better define the molecular mechanisms underlying the phagocytic defects in HIV-infected macrophages. We have shown that the uptake of particulate material, opsonized particles, bacteria or fungi, was inhibited in HIV-infected macrophages 7. Given that this inhibition is partial, we then set out to analyze the fate of the internalized phagosomes in HIV infected human macrophages 8. Because phagosome maturation is tightly connected with migration to the cell center and fusion with lysosomes, a defect in phagosomal maturation can be due to modifications of the trafficking modalities in the infected cell. The method described here uses IgG-opsonized Sheep Red Blood Cells (IgG-SRBCs) as a model to target receptor-mediated phagocytosis and in particular receptors for the Fc portion of immunoglobulins (FcR). These particles are easier to image in bright field (BF) than latex beads because extracellular and intracellular SRBCs show different refraction properties 9. To measure the velocity of phagosomes moving towards the nucleus in HIV-infected macrophages, we used a fluorescent virus 10 and set up a simple manual tracking method that is described here. The method does not require advanced programming and simply uses ImageJ. It is amenable to adherent cells and any type of particle or pathogen that can be visualized with bright field microscopy or with fluorescent imaging.

Protocol

The protocol has to be carried out in strict accordance with national and international legislations and local regulations. Blood from healthy donors that gave their consent to donate blood for research purposes has been obtained from Blood Transfusion Centers with which the Institutions have signed agreement. Special protections must be taken when using human blood. Experiments with HIV-1 must be performed in a biosafety level 3 or 2 (BSL-3 or 2) laboratory according to local legislation.

1. Preparation of Human Monocyte-derived Macrophages (hMDMs) by Density Gradient Centrifugation and Selection by Adhesion

  1. Start with fresh blood from healthy donors (9 ml). Dilute the entire volume of fresh blood with sterile 1x phosphate buffered saline (PBS) without Ca2+ and Mg2+ to obtain a final volume of 70 ml and gently add the diluted blood into two 50 ml conical tubes (35 ml per tube), on top of 15 ml of a neutral, highly branched, high-mass, hydrophilic polysaccharide in solution already in each tube.
  2. Centrifuge both tubes of blood at 537 x g for 20 min at 20 °C without brake. Then collect the peripheral blood mononuclear cells (PBMCs) contained in the cloudy cell ring at the interface and transfer them into a new 50 ml tube containing 15 ml of 1x PBS without Ca2+ and Mg2+.
  3. Centrifuge the cells at 218 x g for 5 min at 20 °C and resuspend the pellet in 45 ml of 1x PBS without Ca2+ and Mg2+.
  4. Centrifuge the cells at 218 x g for 5 min at 20 °C, resuspend the pellet in 10 ml of 1x PBS without Ca2+ and Mg2+, and count the cells by diluting to a final dilution of 1/200 in Trypan Blue.
  5. Centrifuge the cells at 218 x g for 5 min at 20 °C and resuspend the pellet in RPMI (Roswell Park Memorial Institute) 1640 medium supplemented with 2 mM L-glutamine and 100 µg/ml penicillin-streptomycin to have 7 x 106 PBMCs per well in 2 ml of medium in each well of a 6 well-plate.
  6. Incubate the plates at 37 °C with 5% CO2 for 2 hr. After 2 hr the monocytes will have adhered to the plastic.
  7. To allow freshly-isolated monocytes to differentiate into hMDMs, aspirate the medium and replace it with 2 ml hMDM medium (RPMI 1640, 10% decomplemented Fetal Calf Serum (FCS), 2 mM L-glutamine and 1% penicillin-streptomycin) supplemented with recombinant human Macrophage Colony Stimulating Factor (rhM-CSF) at a final concentration of 10 ng/ml.
  8. Incubate the cells at 37 °C with 5% CO2 for 11 days (Figure 1).
  9. At day 11 remove the medium and wash 2 times with 2 ml of cold hMDM medium per well. Next wash each well 2 times with 1 ml of cold 1x PBS.
  10. To detach fully differentiated hMDMs, wash each well 1 time with 1 ml of cold 1x PBS with 2 mM ethylenediaminetetraacetatic acid (EDTA) and incubate the cells in 2 ml of cold 1x PBS with 2 mM EDTA per well for 15-60 min at 4 °C.
    NOTE: Alternative methods to detach the cells exist (e.g., trypsin or trypsin-like activities) that might give good results 11.
  11. After detachment (completed by pipetting gently up and down in the well), collect the cells and put them in a 50 ml tube on ice containing 10 ml of cold hMDM medium.
  12. Centrifuge the cells at 218 x g for 5 min at 20 °C, resuspend the pellet in 10 ml of cold hMDM medium, and count the cells by diluting 1/20 in Trypan Blue.
  13. Seed the cells at 1 x 106 hMDMs per 35 mm microscopy grade glass bottom dish and incubate the plates at 37 °C with 5% CO2 for 1 day.

2. Production and Quantification of HIV-1 Viral Stocks

NOTE: NLR4.3 HIV-1 Gag-iGFP (Green Fluorescent Protein) carrying an R5-tropic envelope, gift from M. Schindler 10 is used to infect macrophages and to see infected cells in real time.

  1. Produce viral stocks by transfection of human embryonic kidney 293T cells (2 x 106 in 100 mm dish) with 6 µg of the corresponding proviral DNA using a commercial transfection reagent.
  2. Quantify the infectivity of the virus stocks using the indicator cells HeLa TZM-bl (bearing the ß-galactosidase gene under the control of HIV-1 LTR) using serial dilutions of the viral stocks followed by a ß-galactosidase coloration of the cells and counting of blue cells 12.

3. Infection of hMDMs with HIV-1

  1. Add the virus at a multiplicity of infection (MOI) 0.02-0.03 in 1 ml of hMDM medium to hMDMs (cells plated in 1.13). To control wells add only 1 ml of hMDM medium and incubate the dishes at 37 °C with 5% CO2 for 2 days (Figure 1).
  2. At day 2 wash the cells with hMDM medium 3 times and add 1 ml of fresh hMDM medium per dish. Incubate the cells at 37 °C with 5% CO2 for 6 days (Figure 1).

4. Opsonization of Sheep Red Blood Cells

  1. For the preparation of 7 x 106 SRBCs per dish, wash the SRBCs two times in 100 µl of solution containing 0.1% Bovine Serum Albumin (BSA) in 1x PBS with centrifugation at 600 x g for 4 min.
  2. Resuspend the washed SRBCs in 500 µl 1x PBS/BSA 0.1% with rabbit IgG anti-SRBCs at a sub-agglutinating concentration per 5 µl of SRBCs and incubate with rotation at RT for 30 min.
    NOTE: To determine the sub-agglutinating concentration of anti-SRBCs IgG, prepare serial dilutions of IgG (stock concentration at 13.1 mg/ml) from 1/50 to 1/25,600 in 20 µl in a 96-well plate. Add 2 x 106 SRBCs in 20 µl in each well and put the plate in a dark room during several hr. The sub-agglutinating concentration is the dilution of the well just before the well with agglutination (IgG+SRBCs forming a network).
  3. After rotation, centrifuge the IgG-opsonized-SRBCs at 600 x g for 4 min and wash with 100 µl of 1x PBS/BSA 0.1% with centrifugation at 600 x g for 4 min.
  4. Resuspend the IgG-opsonized-SRBCs in pre-warmed Phenol red-free RPMI medium supplemented with 2 mM L-glutamine and 1% penicillin-streptomycin (1 ml/dish).

5. Live Cell Video Microscopy Phagocytosis Assay

  1. Use a confocal imaging system such as a spinning disk system equipped with a heating chamber at 37°C with CO2 passing through a bottle with water for humidification.
  2. Turn on the heating chamber prior to the experiment to have the microscope stage at 37 °C before the beginning of the phagocytosis assay. Turn on the microscope and computer, and load the imaging software.
  3. Optimize the imaging settings such as scanning speed, magnification, resolution, etc. to have at least one cell per field and to image one frame every minute between 60 to 120 min.
    NOTE: Here, the sample is imaged one frame every minute during 60 min with 63X lens.
  4. Place the imaging dish on the microscope stage. Adjust the focus and the location to find just one whole HIV-1 infected macrophage in the field. Use appropriate excitation/emission settings based on the used imaging system and probe. Include a bright field (BF) channel to observe phagosomes (Figure 1ii). Optimize the appearance of the different channel images by adjusting the percentage of transmitted light and exposure time.
    NOTE: Here, NLR4.3 HIV-1 Gag-iGFP was excited using a 491 nm laser with 50 msec of time exposure with 20% of laser (Figure 1i).
  5. Remove the imaging dish and add 1 ml of SRBC suspension at 7 x 106 SRBCs/ml to the dish (Figure 1).
  6. Centrifuge at 500 x g for 2 min at RT to synchronize phagocytosis, record the time at the end of this centrifugation and return the dish to the stage.
  7. Optimize the focus and capture GFP and BF images in Z-stacks (throughout the thickness of the cell with a step-distance of 0.3 µm – usually 20 planes) every minute for at least 1 hr. Save the time-lapse video in the native file-format of the used imaging system.
    NOTE: Here, time-lapse movies were saved in the native format, *.stk files.

6. Analysis of the Time-lapse Movies

  1. For video editing, click on the drop down menu "Apps" and on the tab "Review Multi Dimensional Data" in the video editing software.
    1. To open the file, click on "Select Base File" then on "Select Directory". In the "Data sets" box, select the acquisition to analyze (in .nd format) and click on "View". The data are represented in a table with time in the column and Z-plan in the line.
    2. To represent the infection in a Z-projection (Figure 2, left panels), select 491 nm wavelength in the "Wavelengths" box and click on the "Z projection" tab with "all planes".
    3. To analyze a time sequence, select BF wavelength in the "Wavelengths" box and choose the optimal plane on the Z-axis to distinguish external SRBCs (Figure 2, red arrowhead), internal SRBCs (Figure 2, red circle) and the nucleus (Figure 2, blue circle).
    4. To save the video montages, click on "Selection [X's]" tab and then on "Load Image(s)". Finally, save the loaded images in .tif format and open them next on ImageJ software.
  2. Use the plugin "Manual Tracking" on the ImageJ software to measure the position of the nucleus and the different phagosomes observed in BF channel (Figure 3).
    1. Download the "Manual Tracking" plugin on the ImageJ website. On ImageJ, open the plugin and the image sequence to be analyzed (Figure 3, step 1 and 2).
    2. Enter the settings such as "Time Interval" which represents amount of time between adjacent frames, and the "x/y calibration" which represents the distance per pixel (Figure 3, step 3).
      NOTE: Here, save the image sequence with a time interval of 1 min between each frame and x/y calibration of 0.205 µm because the 63X zoom and a camera with pixel size of 6.45 x 6.45 µm2 are used.
    3. To start the tracking, click on "Add track" (Figure 3, step 4) and click on an SRBC center at the first time when it is internalized. The next frame appears automatically.
    4. Continue to click on the SRBC center in all frames to have different positions during the time (Figure 3, step 6 in red box).
      1. Start to track the nucleus to have its position in all frames by clicking on its center. Next track the phagosomes (by clicking on its center) one by one at the time (frame) of their internalization, different in function of SRBCs. For convenience to see SRBC on BF channel, use the "Brightness & contrast" window during the tracking (Figure 3, step 5).
    5. Between each SRBC tracking, click on "Add track" (Figure 3, step 4) to have a new track. The number of the tracking will be changed in the second column, "Track n°" of the results table (Figure 3, step 6).
    6. Save the data in a spreadsheet to continue to the next step of the analysis.
  3. Use spreadsheet software to calculate the travelled distance of phagosomes containing SRBCs towards the nucleus and the velocity of the phagosomes during the first 5 min after internalization of SRBCs (Figure 4).
    1. Open the spreadsheet table and a new spreadsheet file. Transfer into this new file the following parameters only, time, the x- and y- coordinate of the nucleus and all SRBCs (Figure 4A).
    2. To calculate the distance between SRBCs and the nucleus with only their coordinates, consider the nucleus and a SRBC in a XY-coordinate plane (Figure 4B).
      NOTE: The distance between two points is the length of the path connecting them. In the plane, the distance between SRBC and the nucleus is given by the Pythagorean theorem.
      1. If c (the distance between the nucleus and the SRBC) denotes the length of the hypotenuse and a and b denote the lengths of the other two sides, express Pythagoras' theorem as the Pythagorean equation:
        figure-protocol-12856
        NOTE: At the same time, on the orthonormal, the horizontal distance a is (xnucleus-xSRBC) and the vertical distance b is (ynucleus-ySRBC).
      2. Thus, calculate the distance between the nucleus and the SRBC (Figure 4A, purple box) by:
        figure-protocol-13262
        NOTE: Multiply the obtained distance value (in pixels) by x/y calibration to have the distance in µm. Here, the x/y calibration is 0.205 µm.
      3. At each time, subtract the distance between the nucleus and the SRBC to the initial distance (Figure 4C).
      4. Plot the measurement against the time for the first 5 min. Apply a linear trend-line (Figure 5A) to the plot and determine the slope of the linear trend-line that represents the phagosome velocity towards the nucleus during the first 5 min after SRBC internalization.
      5. Collate the data to calculate the average and statistical error of the velocity values and plot them in an appropriate form using the appropriate software (Figure 5B).

Results

FcR-mediated phagocytosis by HIV-1-infected and non-infected hMDMs is described here using IgG-opsonized SRBCs as model targets (Figure 1). The critical steps of this protocol are the preparation of hMDMs and the infection with HIV-1. Indeed, the yield and quality of differentiated macrophages varies among donors, as well as the infection rate with efficiencies in the range of 10-40%. In addition, the preparation of IgG-opsonized-SRBCs is also important to avoid damaging ...

Discussion

This technique has several critical steps. Firstly, the preparation of hMDMs and their infection by HIV-1 is critical because the percentage of infection is donor dependent. Of note, we have decided to use macrophages that are not polarized in vitro prior to infection, because the status of macrophages potentially encountered by the virus in vivo has not been well characterized so far. We checked the expression of several surface markers, indicating that the macrophages are neither M1 nor M2, and verifi...

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Dr Jamil Jubrail for reading the manuscript. This work was supported by grants from CNRS, Inserm, Université Paris Descartes, Agence Nationale de la Recherche (2011 BSV3 025 02), Fondation pour la Recherche Médicale (FRM DEQ20130326518 including a doctoral fellowship for GLB) and Agence Nationale de Recherche sur le SIDA et les hépatites virales (ANRS, including a post-doctoral fellowship for CD) to FN. A. Dumas was supported by doctoral fellowships from Université Paris Descartes and Sidaction.

Materials

NameCompanyCatalog NumberComments
Falcon 100mm TC-Treated Cell Culture DishCorning353003For viral production
Glass Bottom Dishes 35 mm uncoated 1.5MatTek corporationP35G-1.5-14-C CaseFor acquisition
Falcon Tissue Culture Plates 6-wellThermo Fischer ScientificCorning. Inc. 353934For human monocyte-derived macrophages
Ficoll-Plaque PLUSDominique Dutscher17-1440-03a neutral, highly branched, high-mass, hydrophilic polysaccharide in solution for density centrifugation
DPBS, no calcium, no magnesiumThermo Fischer Scientific14190-094Room temperature
Dulbecco's Modified Eagle Medium (DMEM) 1X, liquid (High Glucose)GIBCO, Molecular probes31966-021Conserved at 4°C ; for HEK cells culture
RPMI 1640 medium GLUTAMAX  SupplementLife technologies61870-010Conserved at 4°C; for hMDMs culture
Fœtal Calf Serum (FCS) EurobioCVFSVF0001Conserved at -20°C ; decomplemented
Penicillin-Streptomycin (10,000 U/mL)Thermo Fischer Scientific15140-122Conserved at -20°C ; for hMDMs culture
RPMI 1640 medium, no phenol red (10x500 ml)Life technologies11835-105Warm in 37°C water bath before use ; for phagocytosis assay
FuGENE6 Transfection ReagentPromegaE2692Conserved at 4°C ; for viral production
Sheep red blood cells (SRBCs)EurobioDSGMTN00-0QConserved in Alsever buffer at 4°C before use
Anti-sheep red blood cells IgGMP Biomedicals55806Conserved at 4°C
Bovine Serum Albumin heat shock fraction, pH 7, ≥98% SigmaA7906Conserved at -20°C
Inverted microscope DMI600Leica
Confocal Spinning Disk Unit  CSU-X1M1Yokogawa
491 nm 50mW laserCOBOLT CALYPSO
HCX PL APO CS ObjectifLeicaObjective lens ; Magnification 100x ; Numerical aperture 1.40 ; Immersion oil
CoolSnap HQ2 (FireWire) CameraPhotometricsPixel size 6.45 x 6.45 µm ; Definition 1392 x 1040 ; Encoding the image in 14 Bit
Metamorph 7.7.5 softwareMolecular DevicesFor the control of the microscope
GraphPad Prism softwareFor the statistics analysis

References

  1. Flannagan, R. S., Jaumouille, V., Grinstein, S. The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61-98 (2012).
  2. Niedergang, F. . Encyclopedia of Cell Biology. 2, 751-757 (2016).
  3. Blocker, A., Griffiths, G., Olivo, J. C., Hyman, A. A., Severin, F. F. A role for microtubule dynamics in phagosome movement. J Cell Sci. 111 (Pt 3), 303-312 (1998).
  4. Blocker, A., et al. Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol. 137, 113-129 (1997).
  5. Flannagan, R. S., Cosio, G., Grinstein, S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 7, 355-366 (2009).
  6. Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S., Gordon, M. A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 379, 2489-2499 (2012).
  7. Mazzolini, J., et al. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood. 115, 4226-4236 (2010).
  8. Dumas, A., et al. The HIV-1 protein Vpr impairs phagosome maturation by controlling microtubule-dependent trafficking. J Cell Biol. 211, 359-372 (2015).
  9. Greenberg, S., el Khoury, J., Kaplan, E., Silverstein, S. C. A fluorescence technique to distinguish attached from ingested erythrocytes and zymosan particles in phagocytosing macrophages. J. Immunol. Methods. 139, 115-122 (1991).
  10. Koppensteiner, H., Banning, C., Schneider, C., Hohenberg, H., Schindler, M. Macrophage internal HIV-1 is protected from neutralizing antibodies. J Virol. 86, 2826-2836 (2012).
  11. Gartner, S. The macrophage and HIV: basic concepts and methodologies. Methods Mol Biol. 1087, 207-220 (2014).
  12. Wei, X., et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother. 46, 1896-1905 (2002).
  13. Harrison, R. E., Bucci, C., Vieira, O. V., Schroer, T. A., Grinstein, S. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol Cell Biol. 23, 6494-6506 (2003).
  14. Toyohara, A., Inaba, K. Transport of phagosomes in mouse peritoneal macrophages. J Cell Sci. 94 (Pt 1), 143-153 (1989).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Phagosome MigrationPhagosome VelocityHIV 1 Infected MacrophagesLive Cell ImagingConfocal MicroscopyPhagocytosis AssaySheep bred Blood CellsGFP positiveTime lapse VideoVideo Editing SoftwareManual Tracking Method

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved